Valuation Incyte Corporation Sao Paulo

Stocks

Market Closed - Sao Paulo 05:34:43 24/10/26 am AEDT			5-day change	1st Jan Change
288.27 ^BRL	+2.54%		+2.54%	+4.03%

03:51pm	Genmab Partners with Incyte on Clinical Trial for Metastatic Colorectal Cancer Treatment	MT
24/10	Incyte and Genmab A/S Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16,213	17,869	14,072	13,306	19,391	23,454	-	-
Change	-	10.21%	-21.25%	-5.44%	45.73%	20.96%	-	-
Enterprise Value (EV) ¹	13,865	14,630	10,416	11,148	16,293	19,185	17,508	15,538
Change	-	5.52%	-28.81%	7.03%	46.15%	17.75%	-8.74%	-11.25%
P/E	17.2x	52.8x	23.7x	460x	15.4x	64.5x	16.3x	15.1x
PBR	4.32x	4.09x	2.71x	3.88x	3.79x	4.03x	3.04x	2.41x
PEG	-	-0.8x	0.3x	-4.9x	0x	-0.9x	0x	1.96x
Capitalization / Revenue	5.43x	5.26x	3.81x	3.14x	3.77x	3.95x	3.76x	3.58x
EV / Revenue	4.64x	4.31x	2.82x	2.63x	3.17x	3.23x	2.81x	2.37x
EV / EBITDA	21.5x	24.5x	14.8x	22.2x	9.53x	25.3x	8.33x	7.53x
EV / EBIT	23.7x	25.2x	16.8x	26.9x	10.1x	22.4x	7.65x	6.09x
EV / FCF	24.4x	16.4x	22.4x	44.8x	-	24.9x	10.7x	8.29x
FCF Yield	4.1%	6.1%	4.45%	2.23%	-	4.01%	9.33%	12.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	4.27	1.52	2.65	0.15	6.41	1.794	7.1	7.647
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,986	3,395	3,696	4,241	5,141	5,937	6,241	6,555
EBITDA ¹	643.6	597.7	703.2	503.1	1,709	758.5	2,101	2,065
EBIT ¹	585.8	579.4	620.5	413.9	1,616	857.1	2,288	2,553
Net income ¹	948.6	340.7	597.6	32.62	1,287	376.8	1,483	1,666
Net Debt ¹	-2,348	-3,239	-3,656	-2,158	-3,098	-4,269	-5,946	-7,917
Reference price ²	73.40	80.32	62.79	69.07	98.77	115.71	115.71	115.71
Nbr of stocks (in thousands)	220,891	222,475	224,109	192,650	196,323	202,698	-	-
Announcement Date	8/2/22	7/2/23	13/2/24	10/2/25	10/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.33x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.50x	7.04x	18.70x	2.12%	444.85B
Weighted average by Cap.	35.23x	8.29x	20.40x	1.8%